Novel Medication as a Potential Smoking Cessation Aid
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 25 - 55 |
| Updated: | 2/1/2019 |
| Start Date: | January 2015 |
| End Date: | May 2017 |
The purpose of this study is to provide preliminary information assessing if levomilnacipran
may be effective at increasing smoking cessation rates.
may be effective at increasing smoking cessation rates.
Inclusion Criteria:
- Be between 25 years old and 55 years old
- Smoke a minimum number of cigarettes per day
- Indicate motivation to quit smoking
Exclusion Criteria:
- Current or history of medical or psychiatric conditions that could interfere with
measures being studied or that could be affected by the study medication
- Use of medication that could interfere with measures to be studied or that could be
expected to interact with levomilnacipran
- Are pregnant or breast feeding
The investigators will evaluate if there are other reasons why someone may not be eligible
to participate
We found this trial at
1
site
Click here to add this to my saved trials
